The largest database of trusted experimental protocols

Bit serum replacement

Manufactured by Thermo Fisher Scientific

BIT serum replacement is a cell culture media supplement that can be used as a substitute for traditional fetal bovine serum (FBS). It provides a serum-free alternative for cell growth and maintenance in various in vitro applications.

Automatically generated - may contain errors

2 protocols using bit serum replacement

1

Transfection and Analysis of CD34+ HPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary CD34+ HPCs were thawed and recovered overnight in stem cell media (IMDM containing 10% BIT serum replacement (Invitrogen), penicillin/streptomycin and stem cell cytokines (SCF, FLT3L, IL-3, IL-6). Following recovery, HPCs were transfected using the Amaxa 4D system and the Primary Cell P3 solution according to the manufacturer’s instructions (Lonza). HPCs were transfected with 1ug pSIREN plasmid DNA per 106 cells using either program EH-100 or EO-100. HPCs were recovered in stem cell media for 48hrs, then isolated by FACS (BD FACS Aria equipped with 488, 633 and 405 lasers, run FACS DIVA software) for a pure population of viable, CD34+, GFP+ HPCs. Pure populations of sorted HPCs were plated either at 500 cells/mL in Methocult H4434 (Stem Cell Technologies) in 6 well plates in triplicate for myeloid colony assays, or at 104 cells/mL in stem cell media, 200uL/well in 96 well plates for proliferation assays. Total and specific myeloid colony types were enumerated at 7 and 14 days using a standard microscope and standard protocols as previously described [63 ]. Proliferation was assessed at indicated times by Trypan Blue exclusion and manual counting.
+ Open protocol
+ Expand
2

Myeloid Colony Assay of HCMV-Infected CD34+ HPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary CD34+ HPCs were thawed and recovered overnight in stem cell media (Iscove’s Modified Dulbecco’s Medium (IMDM) containing 10% BIT serum replacement (Invitrogen), penicillin/streptomycin and stem cell cytokines (SCF, FLT3L, IL-3, IL-6 (Peprotech)) and infected with HCMV at a MOI of 3 or transfected with 1ug endotoxin-free plasmid stocks using the P3 primary cell kit and 4D AMAXA (Lonza). All treated HPCs were isolated by FACS (BD FACS Aria equipped with 488, 633 and 405 lasers, running FACS DIVA software) for a pure population of viable, CD34+, GFP+ HPCs. At indicated times, viable CD34+ HPCs were plated in Methocult H4434 (Stem Cell Technologies) in 35mm dishes or 6 well plates in triplicate for myeloid colony assays. Total and specific myeloid colonies were enumerated manually at 7 and 14 days using a standard microscope. Experiments were performed at least in duplicate. Neutralization of TGF-β was performed by treating supernatants with 1ug/mL anti-TGF-β antibody (clone 1D11, MAB1835, R&D) prior to combining with CD34+ HPCs and plating for myeloid colony assays as above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!